1421 related articles for article (PubMed ID: 23965175)
21. Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors.
Angapelly S; Ramya PVS; Angeli A; Del Prete S; Capasso C; Arifuddin M; Supuran CT
Bioorg Med Chem; 2017 Oct; 25(20):5726-5732. PubMed ID: 28887000
[TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
[TBL] [Abstract][Full Text] [Related]
23. Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
Nishimori I; Minakuchi T; Onishi S; Vullo D; Cecchi A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2007 Dec; 15(23):7229-36. PubMed ID: 17826101
[TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
Sarikaya B; Ceruso M; Carta F; Supuran CT
Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
[TBL] [Abstract][Full Text] [Related]
26. Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms.
Buemi MR; De Luca L; Ferro S; Bruno E; Ceruso M; Supuran CT; Pospíšilová K; Brynda J; Řezáčová P; Gitto R
Eur J Med Chem; 2015 Sep; 102():223-32. PubMed ID: 26276436
[TBL] [Abstract][Full Text] [Related]
27. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT
Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250
[TBL] [Abstract][Full Text] [Related]
28. New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII.
Ceruso M; Bragagni M; AlOthman Z; Osman SM; Supuran CT
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):430-4. PubMed ID: 25089707
[TBL] [Abstract][Full Text] [Related]
29. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors.
Ceruso M; Antel S; Scozzafava A; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(2):205-11. PubMed ID: 25792500
[TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
[TBL] [Abstract][Full Text] [Related]
32. Structural study of the location of the phenyl tail of benzene sulfonamides and the effect on human carbonic anhydrase inhibition.
Güzel-Akdemir O; Biswas S; Lastra K; McKenna R; Supuran CT
Bioorg Med Chem; 2013 Nov; 21(21):6674-80. PubMed ID: 24012377
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII.
D'Ascenzio M; Carradori S; De Monte C; Secci D; Ceruso M; Supuran CT
Bioorg Med Chem; 2014 Mar; 22(6):1821-31. PubMed ID: 24560739
[TBL] [Abstract][Full Text] [Related]
34. New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies.
Carradori S; Mollica A; Ceruso M; D'Ascenzio M; De Monte C; Chimenti P; Sabia R; Akdemir A; Supuran CT
Bioorg Med Chem; 2015 Jul; 23(13):2975-81. PubMed ID: 26007302
[TBL] [Abstract][Full Text] [Related]
35. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
Khloya P; Ceruso M; Ram S; Supuran CT; Sharma PK
Bioorg Med Chem Lett; 2015 Aug; 25(16):3208-12. PubMed ID: 26105196
[TBL] [Abstract][Full Text] [Related]
36. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
[TBL] [Abstract][Full Text] [Related]
37. Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII.
Kumar S; Ceruso M; Tuccinardi T; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2907-2913. PubMed ID: 27166574
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
Brzozowski Z; Sławiński J; Innocenti A; Supuran CT
Eur J Med Chem; 2010 Sep; 45(9):3656-61. PubMed ID: 20554082
[TBL] [Abstract][Full Text] [Related]
39. Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
Carradori S; De Monte C; D'Ascenzio M; Secci D; Celik G; Ceruso M; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2013 Dec; 23(24):6759-63. PubMed ID: 24189056
[TBL] [Abstract][Full Text] [Related]
40. Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII.
Eldehna WM; Fares M; Ceruso M; Ghabbour HA; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA; Supuran CT
Eur J Med Chem; 2016 Mar; 110():259-66. PubMed ID: 26840366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
